Legend Biotech Corp

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC LEGN

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/13/2026

Shares

228,229

Value ($000)

6,591

Weight

0.0%

2020 Q2 - 2026 Q2 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/13/2026	6,591	0.0%	228,229	6/30/2026
2025 Q2	8/14/2025	5,193	0.0%	146,322	6/30/2025
2025 Q1	5/19/2025	3,850	0.0%	113,455	3/31/2025
2024 Q4	2/14/2025	4,440	0.0%	136,438	12/31/2024
2024 Q3	11/14/2024	4,886	0.0%	100,257	9/30/2024
2024 Q2	8/14/2024	4,718	0.0%	106,533	6/30/2024
2024 Q1	5/15/2024	18,528	0.0%	330,323	3/31/2024
2023 Q4	2/14/2024	18,075	0.0%	300,406	12/31/2023
2023 Q3	11/13/2023	17,626	0.0%	262,405	9/30/2023
2023 Q2	8/11/2023	10,341	0.0%	214,458	6/30/2023
2023 Q1	5/15/2023	10,341	0.0%	214,458	3/31/2023
2022 Q4	2/14/2023	9,110	0.0%	182,497	12/31/2022
2022 Q3	11/14/2022	20,191	0.0%	494,876	9/30/2022
2022 Q2	8/12/2022	26,683	0.0%	485,139	6/30/2022
2022 Q1	5/16/2022	6,001	0.0%	165,132	3/31/2022
2021 Q4	2/14/2022	5,609	0.0%	120,334	12/31/2021
2020 Q2	8/14/2020	1,064	0.0%	25,000	6/30/2020